Valuation: Procyon Corporation

Market Cap 1.55M 1.35M 1.25M 1.15M 2.17M 149M 2.21M 14.89M 5.84M 72.74M 5.81M 5.68M 251M P/E 2023
-25x
P/E 2024 -5.75x
Enterprise Value 1.06M 931K 859K 789K 1.5M 102M 1.52M 10.25M 4.02M 50.07M 4M 3.91M 173M EV / Sales 2023
0.34x
EV / Sales 2024 0.28x
Free-Float
35.53%
Yield 2023 *
-
Yield 2024 -
1 day-39.29%
1 week-15.42%
Current month-15.42%
1 month-15.42%
3 months-39.29%
6 months+40.50%
Current year+40.50%
1 week 0.17
Extreme 0.17
0.28
1 month 0.17
Extreme 0.17
0.28
Current year 0.12
Extreme 0.12
0.28
1 year 0.1
Extreme 0.1
0.28
3 years 0
Extreme 0
0.34
5 years 0
Extreme 0
0.64
10 years 0
Extreme 0
1
Manager TitleAgeSince
Chief Executive Officer 49 08/01/2018
Chief Executive Officer 56 21/09/2005
Director TitleAgeSince
Director/Board Member 49 31/12/2005
Director/Board Member 56 30/11/2006
Chairman 79 31/08/2005
Date Insider Type Main position Quantity % Market Cap.
30/07/24Other

Director

7,200 0.0888%
30/07/24Other

Director

5,600 0.0691%
30/07/24Other

Director

12,848 0.1585%
Change 5-day change 1-year change 3-year change Capi.($)
-39.29%-15.42%-10.53%-31.45% 1.39M
+2.42%-2.72%+49.89%+164.76% 1,031B
+0.88%-3.59%+51.59%+57.03% 595B
+2.86%+0.84%+32.23%+86.91% 431B
-0.03%-1.61%+28.84%+23.08% 326B
+0.84%-1.01%+29.35%+44.89% 277B
+0.53%-5.60%+20.79%+23.59% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.61%+1.24%+23.11%+61.57% 193B
+0.99%-1.33%+21.11%+71.71% 164B
Average -2.67%-3.41%+22.38%+46.47% 350.43B
Weighted average by Cap. +1.59%-4.31%+34.79%+80.69%

Financials

2023 2024
Net sales 4.69M 4.1M 3.78M 3.47M 6.58M 451M 6.7M 45.13M 17.71M 220M 17.6M 17.21M 760M 4.98M 4.36M 4.02M 3.7M 7M 480M 7.12M 47.99M 18.83M 234M 18.72M 18.31M 808M
Net income -50.24K -43.93K -40.52K -37.25K -70.58K -4.83M -71.79K -484K -190K -2.36M -189K -185K -8.14M -341K -298K -275K -253K -479K -32.83M -487K -3.28M -1.29M -16.04M -1.28M -1.25M -55.3M
Net Debt -427K -374K -345K -317K -601K -41.13M -611K -4.12M -1.62M -20.1M -1.61M -1.57M -69.29M -482K -422K -389K -357K -677K -46.39M -689K -4.64M -1.82M -22.67M -1.81M -1.77M -78.15M
Logo Procyon Corporation
Procyon Corporation operates through its subsidiary AMERX Health Care Corporation (AMERX). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. It provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.
Employees
20
Date Price Change Volume
14/07/26 US$0.1700 -39.29% 30,000
13/07/26 US$0.2800 0.00% 5,000
  1. Stock Market
  2. Stocks
  3. PCYN Stock